Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Theranova, L.L.C.
Age
18–100
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
18-100 years, inclusive
Diagnosis of episodic migraine with and without aura per International Headache Society diagnostic criteria
4-14 migraine days per month
Ability to provide informed consent
Demonstrates no contraindication to the use of electrical nerve stimulation
Capable and willing to follow all study-related procedures
You may not be if
Currently pregnant or breastfeeding, pregnant within the past 6 months or intends to become pregnant during the enrollment period
Diagnosis of chronic migraine or other forms of primary or secondary headache disorders, including medication overuse headache per International Headache Society diagnostic criteria
Any medical condition that would, in the opinion of the investigator, make the subject ineligible
Has received botulinum toxin injections within the past 3 months
Is currently implanted with an electrical and/or neurostimulator devic, including but not limited to cardiac pacemaker or defibrillator, vagal neurostimulator, sacral stimulator, bone growth stimulator, or cochlear implant
Use of investigational drug/device therapy within the past 4 weeks
Deemed unsuitable for enrollment in study by the investigator based on subjects' history or physical examination (including bleeding disorders, anticoagulant medications and peripheral neuropathy)
No changes in preventive medications (or other medications determined to potentially interfere with the study) in the previous 30 days and no intent to change it during the study
Clareo Health | Evaluation of Peripheral Nerve Stimulation for Acute Treatment of Migraine Pain
